Art
J-GLOBAL ID:201502239477565320   Reference number:15A0110440

The usefulness of a disease severity staging classification system for IPF in Japan: 20 years of experience from empirical evidence to randomized control trial enrollment

日本におけるIPFの疾患重症度ステージング分類システムの有用性:経験的実証からランダム化比較試験参加までの20年の経験
Author (3):
Material:
Volume: 53  Issue:Page: 7-12  Publication year: Jan. 2015 
JST Material Number: W2316A  ISSN: 2212-5345  Document type: Article
Article type: 文献レビュー  Country of issue: Netherlands (NLD)  Language: ENGLISH (EN)
Thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
Semi thesaurus term:
Thesaurus term/Semi thesaurus term
Keywords indexed to the article.
All keywords is available on JDreamIII(charged).
On J-GLOBAL, this item will be available after more than half a year after the record posted. In addtion, medical articles require to login to MyJ-GLOBAL.
,...
   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A0110440&from=J-GLOBAL&jstjournalNo=W2316A") }}
JST classification (1):
JST classification
Category name(code) classified by JST.
Clinical medicine on respiratory system in general 
Substance index (2):
Substance index
Chemical Substance indexed to the Article.
Reference (21):
  • Zappala CJ, Latsi PI, Nicholson AG, et al. Marginal decline in forced vital capacity is associated with a poor outcome in idiopathic pulmonary fibrosis. Eur Respir J 2010;35:830-6.
  • Flaherty KR, Andrei AC, Murray S, et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and sixminute walk test. Am J Respir Crit Care Med 2006;174:803-9.
  • Collard HR, King Jr TE, Bartelson BB, et al. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2003;168:538-42.
  • King Jr TE, Safrin S, Starko KM, et al. Analysis of efficacy endpoints in a controlled trial of interferon-gamma 1 b for idiopathic pulmonary fibrosis. Chest 2005;127:171-7.
  • Japanese Respiratory Society's Committee formulating diagnosis and treatment guideline for diffuse lung diseases. Clinical diagnostic and treatment guidance for idiopathic interstitial pneumonias. Tokyo, Nankodo; 2004.
more...

Return to Previous Page